Saxenda is approved for: Adults Adults with obesity (BMI of 30 kg/m or greater) Adults who are overweight (BMI of 27 kg/m or greater) and have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol Children aged 12 and older Adolescents with obesity who weigh more than 60 kg (132 pounds) Limitations of use Saxenda should not be used together with other medicines that contain liraglutide, such as Victoza, or with any other GLP-1 receptor agonist, such as Ozempic, Wegovy, or Trulicity The safety and effectiveness of Saxenda in children aged 12 to 17 years who have type 2 diabetes have not been established
Upon approval, they will issue a prescription, arrange your delivery schedule, and walk you through proper usage
Indian doctors said the analysis was unlikely to change how these drugs are prescribed here in the short term Indian practice still runs largely on a body mass index cut-off, not a comparison between drugs but that the picture is set to change as evidence accumulates
Reducing feeling of hunger Improve quality of life Improved body composition by reducing excess body fat, Reducing abnormal fat abdominal fat averagely 20% Increasing the proportion of lean body mass
Glycine is not necessary in the same way B12 is
.png.jpg)
